Navigation Links
CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts

By using pathogenic fungi as model systems for understanding fungal diseases, two groups of researchers are reporting new work that offers insight into how carbon dioxide (CO2) governs the morphogenic changes that allow pathogenic fungi to survive in different environments and invade the human body, and they provide new evidence for how CO2 sensing and metabolism utilize evolutionarily conserved enzymes to control the growth and sexual reproduction of pathogenic microbes.

The two studies are reported by Joseph Heitman and colleagues at Duke University Medical Center and by Fritz Mühlschlegel of the University of Kent, Jochen Buck at Cornell University, and their collaborators.

How organisms sense and respond to CO2 at the cellular level is not fully understood, but it is of great importance in understanding the biology of microbes, plants, and animals alike. For example, CO2 levels govern the detection of prey by female mosquitoes, control respiration in mammals, and of course play a critical regulatory role in photosynthesis in algae and plants; in addition, CO2 sensing and transport are involved in many cellular processes and virulence attributes of diverse pathogenic bacteria and fungi--in both B. anthracis, which causes Anthrax, and C. neoformans, which causes meningitis, CO2 induces the production of sugar-based capsules that surround and protect the invading cell from the host during infection.

In their new work, Mühlschlagel and colleagues studied the function of CO2 sensing in two major human fungal pathogens, C. albicans and C. neoformans. Both cause life-threatening, invasive infections in immunocompromised patients--for example, those infected with HIV or undergoing bone-marrow transplantation. The two fungi, which are distantly related in evolution, have different attributes governing their virulence in humans. For C. albicans, a transition between different morphological forms ("yeast" and "filamentous" forms) plays a major role, whereas for C. neoformans, synthesis of a polysaccharide capsule is key.

In the bodies of mammals, the CO2 concentration is more than 150-fold higher (5%) than it is in atmospheric air (0.033%). Consequently, C. albicans and C. neoformans are exposed to dramatically elevated CO2 concentrations when causing systemic disease. In their research, the authors identify CO2 as a physiological signal that induces the pathogenic filamentous transition in C. albicans; they also demonstrate that an ancient group of enzymes called adenylyl cyclases are the so-called chemosensors mediating both the CO2 -dependent filamentation in C. albicans and the capsule biosynthesis in C. neoformans. The authors go on to show that CO2 sensing in C. albicans is essential for superficial (skin) infections, in which yeast must be able to grow despite significantly lowered CO2 levels present at the skin surface. Based on their findings, the authors conclude that CO2 sensing is a vital mediator of fungal virulence in different host environments--for example, at different sites within the body.

In a related paper, Joseph Heitman and colleagues, also using C. neoformans as a model system for understanding fungal disease, provide new evidence that CO2 sensing and metabolism govern growth, sexual reproduction, and virulence of this pathogenic microbe.

In this work, the researchers investigated the CO2-sensing mechanism of C. neoformans. This pathogen normally infects the human host (a high-CO2 environment) from the air (low CO2) in the course of causing deadly fungal meningitis. The authors found that an enzyme called carbonic anhydrase (CA) plays a critical role in the yeast's growth in ambient air; the CA enzyme accomplishes this by providing bicarbonate substrates for fatty-acid biosynthesis and other cellular processes. In contrast, the CA enzyme is dispensible for the yeast's survival in the high- CO2 environment of the host. Another major finding of the work is that f or C. neoformans, high CO2 blocks sexual differentiation, which is known to be a key process for generating infectious spores, and the CA enzyme plays a central role in the process. Together with the accompanying work by Mühlschlegel and colleagues, this study implicates a key role for CO2 in growth and differentiation in the fungal kingdom.

The identification of a link between CO2 sensing and fungal virulence may have broad implications for the study of microbial pathogens and the role of adenylyl cyclase in virulence trait regulation by CO2. Furthermore, it may in time facilitate the development of a new class of antimicrobial agents.


'"/>

Source:Cell Press


Related biology news :

1. Scientists map one of biologys critical light-sensing structures
2. Detection of DNA on nanotubes offers new sensing, sequencing technologies
3. Drug resistance may travel same path as quorum sensing
4. K-Staters design and build a low-cost remote sensing tool for environmental studies
5. Scripps Research study reveals new activation mechanism for pain sensing channel
6. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
7. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
8. Purdue proves concept of using nano-materials for drug discovery
9. FDA Approves New Drug to Treat Type I and Type II Diabetes
10. Canada approves marijuana-based pain spray
11. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: